0001093557-15-000072.txt : 20150311 0001093557-15-000072.hdr.sgml : 20150311 20150311194357 ACCESSION NUMBER: 0001093557-15-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150308 FILED AS OF DATE: 20150311 DATE AS OF CHANGE: 20150311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VALDES JORGE A CENTRAL INDEX KEY: 0001343856 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 15694127 MAIL ADDRESS: STREET 1: C/O DEXCOM INC STREET 2: 5555 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-03-08 0 0001093557 DEXCOM INC DXCM 0001343856 VALDES JORGE A 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 CTO Common Stock 2015-03-08 4 A 0 45000.0 0.0010 A 163748 D Common Stock 2015-03-08 4 J 0 11937.0 59.59 D 151811 D Common Stock 2015-03-08 4 J 0 23667.0 59.59 D 128144 D Common Stock 2015-03-09 4 M 0 8244.0 13.45 A 136388 D Common Stock 2015-03-09 4 S 0 8244.0 58.7735 D 128144 D Common Stock 2015-03-08 4 J 0 11937.0 59.59 A 85620 I by Trust Common Stock 2015-03-08 4 J 0 23667.0 59.59 A 109287 I by Trust Common Stock 2015-03-09 4 S 0 5712.0 59.2446 D 103575 I by Trust Common Stock 2015-03-09 4 S 0 926.0 59.87 D 102649 I by Trust Non-Qualified Stock Option (right to buy) 13.45 2015-03-09 4 M 0 8244.0 58.7735 D 2006-11-01 2015-11-01 Common Stock 8244 24731 D Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. Included in this number are 128,144 unvested restricted stock units, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 47,333 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 35,811 of which were granted on March 11, 2013 and shall vest through March 11, 2016. Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. On November 10, 2014, Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $58.45 to $59.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. This transaction was executed in multiple trades at prices ranging from $59.23 to $59.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. By: Jess Roper For: Jorge A. Valdes 2015-03-11